Assyro AI

FDA Orange Book · active-ingredient family

Cefmetazole sodium

Cefmetazole sodium is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
ZEFAZONE IN PLASTIC CONTAINERRLD×2PHARMACIA AND UPJOHNNDA 050683Dec 29, 1992
ZEFAZONERLD×2PHARMACIA AND UPJOHNNDA 050637Dec 11, 1989

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cefmetazole sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.